Pregled bibliografske jedinice broj: 54388
Alpha-1-antitrypsin deficiency : from detection to therapy
Alpha-1-antitrypsin deficiency : from detection to therapy // Acta pharmaceutica, 50 (2000), 1; 1-16 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 54388 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Alpha-1-antitrypsin deficiency : from detection to therapy
Autori
Dodig, Slavica ; Čepelak, Ivana ; Raos, Miljenko
Izvornik
Acta pharmaceutica (1330-0075) 50
(2000), 1;
1-16
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
alpha-1-antitrypsin; lung; disease; liver disease
Sažetak
Inherited deficiency of alpha-1-antitrypsin is one of the best know abnormalities affecting the lungs. DNA sequence of the responsible gene has been identified, and the gene has been cloned. Genetically engineered alpha-1-antitrypsin has been synthesised and treatment with synthetic protein has been initiated. Many questions remain. The future will clear out the pathogenesis of liver diseases, replaceable, prophylactic and inhalant therapy for specific and nonspecific protection of lung. Early dection of alpha-1-antitrypsin deficiency as well as drug administration are very important for clinical practice. The patient must be educated about environmental control to avoid or eliminate factors that induce lung diseases.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus